Nearly 3,000 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Orlando from Oct. 16–19 for AMCP Nexus 2023, the industry’s premier fall meeting.
Every year, volunteers play a key role in helping us shape engaging national meetings, and this year was no different. AMCP News & Views celebrates the amazing members and health care leaders who stepped up to the plate to volunteer their time at Nexus 2023.
Nonalcoholic steatohepatitis or NASH is a form of Nonalcoholic fatty liver disease or NAFLD, in which the liver is inflamed and damaged due to the buildup of fat in the liver.
AMCP will occasionally publish highlights from AMCP and other conferences designed for those in managed care pharmacy. Highlights include summaries of select featured sessions and posters. Meetings published currently include the AMCP Annual 2023, Psych Congress 2023, and the American Psychiatric Association 2023 Annual Meeting.
October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.
The world of prescription drug care and coverage can be complicated. Read AMCP CEO Susan Cantrell’s blog on AMCP’s inaugural “Access, Affordability, & Outcomes: The Value of Managed Care Pharmacy” annual report to learn how we’re making it more understandable
On Aug. 30, 2023, the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury issued the proposed rule titled “Requirements Related to the Mental Health Parity and Addiction Equity Act. AMCP submitted comments in response to the proposed rule on Oct. 17.